J

Journey Clinical

Ketamine-assisted psychotherapy with medical oversight

Nurse Practitioner / Physician Assistant Spravato Clinician - Multiple Teams

Full-Time
No salary listed
Mid
Chattanooga, TN, USA
In PersonTravel to partner therapist offices within an agreed radius.
Medical, Clinical & VeterinaryAdvanced Practice Providers

About the job

Requirements
  • Active NP or PA license in the state of practice
  • Current, unrestricted DEA registration
  • Willingness to register/associate your DEA registration to partner site address(es) as needed for Spravato operations
  • Comfort with outpatient monitoring and responding to clinical changes (e.g., blood pressure changes, anxiety, dissociation)
  • Strong documentation skills and reliability with protocols
  • Willingness to complete required program training (Spravato REMS-related processes)
  • Ideal candidates will have psychiatry experience; ketamine/esketamine, transcranial magnetic stimulation (TMS), infusion, or other monitoring workflows
Responsibilities
  • Conduct psychiatric intake evaluations and screening to determine Spravato eligibility
  • Prescribe Spravato and initiate documentation for insurance prior authorization
  • Provide on-site clinical support during Spravato dosing sessions (patients self-administer nasal spray)
  • Monitor patients during the observation period (vitals, safety checks, symptom monitoring)
  • Complete required documentation accurately and on time
  • Coordinate with Journey Clinical operations and partner sites to ensure smooth patient flow
  • Support a calm, safe environment for small cohorts (typically 3–4 patients per session block)
Desired Qualifications
  • Psychiatry experience
  • Experience with ketamine/esketamine, TMS, infusion, or other monitoring workflows is preferred

About the company

Journey Clinical offers Ketamine-Assisted Psychotherapy (KAP) for depression, anxiety, and PTSD. It acts as a one-stop treatment partner where a medical consultation leads to ketamine prescription, administration, and accompanying psychotherapy in a coordinated care plan. The approach blends ketamine's effects with structured psychotherapy to tackle symptoms from multiple angles under medical oversight. The company stands out with a patient-centered, collaborative care model and a team of MDs, PhDs, and licensed clinicians delivering personalized, accessible therapy.

Company Size

51-200

Company Stage

Series A

Total Funding

$11.5M

Headquarters

New York City, null

Founded

2020

Get referred to Journey Clinical

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • DEA telemedicine flexibilities stay open through December 31, 2026, supporting remote ketamine prescribing.
  • Journey Clinical says major insurers cover KAP, and patients receive reimbursement in 30 states.
  • The 2026 White House executive order boosts psychedelic medicine attention and future access pathways.

What critics are saying

  • DEA telemedicine relief expires December 31, 2026; tighter rules would break its remote workflow.
  • Georgia's 2026 ketamine-clinic law signals state licensing, ownership, and staffing scrutiny spreading nationwide.
  • FDA ketamine safety warnings and compounding crackdowns threaten prescriber confidence, referrals, and Journey Clinical's existential market.

What makes Journey Clinical unique

  • Journey Clinical runs therapist-led KAP with in-network prescribers across 30 states.
  • It claims the largest U.S. psychedelic-assisted psychotherapy provider network, anchored by thousands of therapists.
  • Its model keeps therapists independent while Journey Clinical handles medical oversight and prescribing.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Flexible Work Hours
  • Remote Work Options
  • Training Programs
  • Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

3%
The Juniper Center
Aug 4th, 2025
What is Ketamine-Assisted Psychotherapy?

For those curious to learn more, The Juniper Center has partnered with Journey Clinical - a platform that connects therapists with licensed prescribers and offers research and resources on KAP for both clients and providers.

Gateway to Solutions
Jun 21st, 2024
Ketamine-Assisted Psychotherapy (KAP) at Gateway to Solutions

Gateway to Solutions, a trusted provider of ketamine-assisted psychotherapy for eight years, has recently partnered with Journey Clinical for a seamless and collaborative KAP experience.

Crain Communications
May 1st, 2024
Compass Pathways, Journey Clinical to develop psilocybin treatment delivery model

Compass Pathways plc (Nasdaq: CMPS) entered into a research collaboration agreement this week with Journey Clinical, a U.S.-based psychedelic-assisted psychotherapy platform.

Journey Clinical
Dec 19th, 2023
Building a Network of KAP Providers with IPI

This October, Journey Clinical launched a partnership with the Integrative Psychiatry Institute (IPI) to support their students and graduates in becoming successful Ketamine-Assisted Psychotherapy providers.

Journey Clinical
Apr 10th, 2023
SXSW Panel: The Business of Psychedelics featuring Myriam Barthes

Journey Clinical partnered up with Fluence to offer some training and then they also needed professional resource in order to grow their practice.